PI research grants span diagnosis, T cell biology, and new treatments
IDF’s 2023 grantees are developing treatments like gene editing and fecal microbiome transplant, advancing genetic diagnoses, and developing techniques to better understand specific primary immunodeficiencies.
Read MoreBlaese awardee is developing a gene editing strategy to treat XLA
Dr. Donald Kohn, winner of the 2023 Michael Blaese Research Grant Award, will use his grant funds to gather crucial pre-clinical data for a gene editing strategy to treat X-linked agammaglobulinemia (XLA). If successful, his strategy could begin clinical trials in 2-4 years.
Read MoreYoung adult with CVID strives to improve others’ lives
Bryan Jirsa, diagnosed with common variable immune deficiency (CVID), played varsity football at Fallston High School in Maryland.
Read MoreBone marrow transplant restores health of boy with CGD
After battling a life-threatening infection, Harry McLachlan, a toddler with chronic granulomatous disease (CGD), is healthy thanks to a bone marrow transplant (BMT).
Read MorePrimary immunodeficiency patient registry moves into a new era
After 30 years at IDF, the United States Immunodeficiency Network (USIDNET) is moving to the Children’s Hospital of Philadelphia (CHOP) and into the genomics era.
Read More
